Wonderly Plus subscribers can listen to Business Wars daily ad-free right now.

Join Wonderly Plus in the Wondery app or on Apple Podcasts.

How do I cope with waiting for results?

It's all I can think about.

Is the cancer going to come back?

I can't sleep.

How do I stop worrying?

We know what goes through your head when you're living with

cancer. The questions, the anxieties. We understand because we've been there too. If you or

someone you care about has been diagnosed with cancer, McMillan Cancer supports online community

can help from day one. It's a free, safe, online forum for people with cancer to connect anonymously.

No question is too big or too small. With over 80,000 members, we get it. We've been there.

Whatever you need to ask, we're here. To join, search McMillan online community.

Thank you. McMillan Online Community. From Wondery, I'm David Brown, and this is Business Awards Daily on this Monday, January 31st.

Happy end of the month, everyone.

Speaking of endings, the emergency authorization of monoclonal antibodies made by two companies

has come to an end. Last week, the FDA said antibody drugs from both Regeneron Inc. and

Eli Lillian company should no longer be used because they aren't effective against the latest

omicron variant of the COVID-19 virus. If regeneron rings a bell, that's because that's the

antibody treatment. One President Donald Trump got shortly after contracting the virus in 2020,

but alas, while it may have helped Trump fight the original strain of COVID, it's just not as effective

for much else. The news didn't come as a surprise to the two pharmaceutical companies. Both have

...